Cargando…

A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes

Introduction. Among atypical antipsychotics, none has been linked to torsade de pointes. In the present study, the electrocardiographic changes induced by olanzapine have been compared with risperidone. Method and Materials. 268 patients were entered into an open study for random assignment to olanz...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoja Shafti, Saeed, Fallah Jahromi, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174968/
https://www.ncbi.nlm.nih.gov/pubmed/25276418
http://dx.doi.org/10.1155/2014/637016
_version_ 1782336429862420480
author Shoja Shafti, Saeed
Fallah Jahromi, Parisa
author_facet Shoja Shafti, Saeed
Fallah Jahromi, Parisa
author_sort Shoja Shafti, Saeed
collection PubMed
description Introduction. Among atypical antipsychotics, none has been linked to torsade de pointes. In the present study, the electrocardiographic changes induced by olanzapine have been compared with risperidone. Method and Materials. 268 patients were entered into an open study for random assignment to olanzapine or risperidone. ECG was taken at baseline and at the end of the treatment. The parameters that had been assessed included Q-T interval (corrected = Q-Tc) and other related parameters. Correction of the observed Q-T interval was done according to Frederica's formula (QTcF). Results. While 14.86% and 25% of the cases in the olanzapine group showed prolongation and shortening of QTcF, respectively, comparable changes in the risperidone group were restricted to its prolongation (32.5%). Comparison of means between baseline QTcF of risperidone group versus its posttreatment measurement showed a significant increment (P = 0.02). Also, the quantity of cases with shortening of QTcF in the olanzapine group was significantly more than its opposite (P = 0.02). Conclusion. Comparable propensity of olanzapine and risperidone for induction of electrocardiographic changes demands adequate cautiousness by clinicians, particularly with respect to shortening of Q-T interval, which was mainly noticeable in the olanzapine group.
format Online
Article
Text
id pubmed-4174968
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41749682014-09-30 A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes Shoja Shafti, Saeed Fallah Jahromi, Parisa Cardiovasc Psychiatry Neurol Clinical Study Introduction. Among atypical antipsychotics, none has been linked to torsade de pointes. In the present study, the electrocardiographic changes induced by olanzapine have been compared with risperidone. Method and Materials. 268 patients were entered into an open study for random assignment to olanzapine or risperidone. ECG was taken at baseline and at the end of the treatment. The parameters that had been assessed included Q-T interval (corrected = Q-Tc) and other related parameters. Correction of the observed Q-T interval was done according to Frederica's formula (QTcF). Results. While 14.86% and 25% of the cases in the olanzapine group showed prolongation and shortening of QTcF, respectively, comparable changes in the risperidone group were restricted to its prolongation (32.5%). Comparison of means between baseline QTcF of risperidone group versus its posttreatment measurement showed a significant increment (P = 0.02). Also, the quantity of cases with shortening of QTcF in the olanzapine group was significantly more than its opposite (P = 0.02). Conclusion. Comparable propensity of olanzapine and risperidone for induction of electrocardiographic changes demands adequate cautiousness by clinicians, particularly with respect to shortening of Q-T interval, which was mainly noticeable in the olanzapine group. Hindawi Publishing Corporation 2014 2014-09-09 /pmc/articles/PMC4174968/ /pubmed/25276418 http://dx.doi.org/10.1155/2014/637016 Text en Copyright © 2014 S. Shoja Shafti and P. Fallah Jahromi. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Shoja Shafti, Saeed
Fallah Jahromi, Parisa
A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes
title A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes
title_full A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes
title_fullStr A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes
title_full_unstemmed A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes
title_short A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes
title_sort comparative study between olanzapine and risperidone regarding drug-induced electrocardiographic changes
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174968/
https://www.ncbi.nlm.nih.gov/pubmed/25276418
http://dx.doi.org/10.1155/2014/637016
work_keys_str_mv AT shojashaftisaeed acomparativestudybetweenolanzapineandrisperidoneregardingdruginducedelectrocardiographicchanges
AT fallahjahromiparisa acomparativestudybetweenolanzapineandrisperidoneregardingdruginducedelectrocardiographicchanges
AT shojashaftisaeed comparativestudybetweenolanzapineandrisperidoneregardingdruginducedelectrocardiographicchanges
AT fallahjahromiparisa comparativestudybetweenolanzapineandrisperidoneregardingdruginducedelectrocardiographicchanges